Robert A. Michael

Rob Michael is the Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 57,000 people worldwide and has provided innovative medicines and products to more than 60 million people in over 175 countries.

Mr. Michael was appointed to the role of chief executive officer in 2024 and previously served as president and chief operating officer of AbbVie and has been a longstanding member of AbbVie’s Executive Leadership Team. From establishing AbbVie’s first financial planning organization, to developing its diversified business strategy, to successfully returning the company to peak revenue within 2 years of the U.S. Humira loss of exclusivity, Mr. Michael has been integral to AbbVie's success and growth over the years. In the role of president and chief operating officer, Mr. Michael was responsible for global commercial operations, finance, corporate human resources, global operations, business development and corporate strategy for the company. He was previously appointed vice chairman and president in 2022, vice chairman, finance and commercial operations in 2021 and chief financial officer in 2018. Mr. Michael has more than 30 years of experience including leadership roles across multiple businesses, including pharmaceuticals, aesthetics, diagnostics, diabetes care and nutrition. He began his career with Abbott as a member of the financial development program.

Mr. Michael earned a bachelor’s degree in accounting from Indiana University Kelley School of Business and a Master of Business Administration from University of California Los Angeles Anderson School of Management.